We have now further characterized the CTL response against the mycobacterial 65-kD hsp. We found that the mycobacterial 65-kD hsp triggers CD4* CTL clones that are specific for different peptide defined epitopes (19, 20) . These CTL not only lyse APCs but also CD4+ or CD8+ CTL clones, including themselves, that carry the proper peptide/HLA class II complex . CD4+ CTL are therefore not by definition resistant to CTL-or self-mediated lysis; in addition, CTL-mediated CTL lysis may represent a novel immunoregulatory pathway in man, since human T cells, in contrast to murine, express MHC class II .
Materials and Methods
Antigens. The recombinant 65-kD hsp of M. bovis BCG was a gift of Dr. J . D. A. van Embden (Bilthoven, The Netherlands). Peptides of the M. leprae 65-kD hsp were made by solid-phase peptide synthesis and checked by analytical reverse-phase HPLC and amino acid analysis as described previously (20) , and were a kind gift of Dr. D. C. Anderson (Seattle, WA) . The Plasmodiumfalciparum CS peptide was a gift ofDr. F. Sinigaglia (Basel, Switzerland) (21) . The sequences of the peptides are given in Table I .
T Cell Clones. The T cell clones used in this study are summarized in Table 1 . Some of them have been described previously with regard to their antigen specificity and HLA class II restriction (19, 20, (22) (23) (24) .
CytotoxicityAssay. After overnight pulsing with antigen (5 Wg/ml), target cells were pelleted, resuspended, and labeled with 100 FACT "Cr sodium chromate (Amersham International, Amersham, UK) during 1 h at 37°C. After three washes, target cells were added to 96-well round-bottomed plates (Costar 3799) in 100 pl ofmedium at 104 cells/well in triplicate wells. Effector cells were then added in 100 Al at the indicated E/T cell ratios. The plates were incubated for 4 h and then centrifuged, after which cell-free supernatants were collected from each well, and "Cr release was counted in a gamma counter. The percent specific lysis was calculated using the following formula : percent specific lysis = [(experimental release -spontaneous release)/(maximal release -spontaneous release)] x 100%. All cultures were set up in Iscove's modified Dulbeccds Medium (Gibco Laboratories, Grand Island, NY) supplemented with penicillin (100 Rg/ml), streptomycin (100 Ag/ml) (both Gibco Laboratories, Grand Island, NY) and 10% pooled human AB serum.
Results 65-kD hsp or CS Peptide-dependent Lysis ofEBVBLCL Targets by CD4+ Cytotoxic T Cell Clones. Peptide pulsed or nonpulsed HLA class II matched EBVBLCL cells were used as target cells for freshly cultured CD4 + HLA class II-restricted T cell clones that recognized specific peptides of the mycobacterial 65-kD hsp (see Table I ). As shown in Fig. 1 , all clones strongly lysed target cells pulsed with the specific peptide but not targets pulsed with irrelevant or no peptide. A control P. falciparum CS peptide-specific CD4+ T cell clone, MGD5, was included that gave similar results . Thus, T cell clones that recognize different peptides in combination with DR or DO restriction elements and that are derived from different individuals, are cytotoxic for peptide-pulsed target cells. Clones NlC8 and W2G2 were able to lyse EBVBLCL that had been pulsed with the purified, whole recombinant 65-kD hsp . Clone RIF9 showed minimal lysis and the other clones no lysis at all of recombinant 65-kD hsp pulsed EBVBLCL . Since these latter clones are able to lyse macrophages under similar conditions (data not shown), these results point to a relative presentation defect of these EBVBLCL to some of the 65-kD hsp-specific T cell clones . This defect is apparently overcome when peptide is used instead of the recombinant 65-kD molecule. One representative experiment (Table II) shows that the level of target cell lysis is dependent on the peptide concentration during the pulsing phase. This further underlines the antigen dependency and specificity of target cell lysis by CD4' clones .
CD4+ 65-kD lup-specific CTL Lyse Themselves and Other CD4' CTL in the Presence of Specific Peptide. Human T cell clones, in contrast to mouse T cells, strongly express MHC class II antigens . Synthetic peptides can bind directly to MHC class II . Since CTL usually are resistant to lysis by self-or other CTL or subcellular CTL components, we investigated ifpeptide pulsed CTL would be susceptible to CTL-mediated lysis. The results in Table III , A and B show that all 65-kD hsp-specific CTL clones lyse themselves as well as other autologous T cell clones that had been pulsed with relevant peptide. Both TCR-a/o and TCRy/S cells (data not shown) are susceptible to lysis. In contrast, an HLA mismatched clone (SCL 5 .12, Table IIIA) is not lysed.
Although EBVBLCL can present (probably processed) native recombinant 65-kD hsp to some T cell clones (W2G2, NIC8 ; Table IIIB), T cell clones are unable to do so (Table IIIB) .
So far, all tested 65-kD hsp peptide-specific CD4+ T cell clones are able to lyse CD4' CTL in the presence of appropriate peptide. Thus, our results show that peptide-specific CD4+ CTL are able to lyse themselves as well as other CD4+ CTL in the presence of specific peptide. CD4+ 65-kD hsp Peptide-specific CTL Lyse HLA Class II Compatible CD8+ CTL Clones in the Presence ofSpecific Peptide. Since most studies addressing the resistance of CTL against self-mediated killing have focused on the "classical" CD8+ CTL, we tested four randomly selected HLA class II compatible CD8+ CTL clones, specific for HLA class I/minor transplantation antigens (6, 25, 26) . CTL C754 .5w4 could only be lysed by effector CTL R2F10 but not RIF9, as expected on the basis of its HLA DR phenotype (Table IV) . The other three CD8+ CTL clones could be lysed by both CD4 + CTL clones, provided that they had been pulsed with the proper 65-kD peptide. The levels of lysis were much lower that those seen with EBVBLCL targets, suggesting a partial but not total protection from CTL-mediated lysis. Thus, peptide-pulsed human CD8+ cytolytic CTL clones can be lysed by CD4+ CTL clones, and therefore are not absolutely resistant against CTL-mediated Lsis .
CD4+ CTL-mediated Lysis Does Not Induce Nonspecific Bystander Lysis. CD4+ T cell clones have been reported to acquire nonspecific lytic activity upon long-term culture in IL-2. Although we found no evidence for nonspecific lysis, we tested whether the presence of a high dose ofrIL-2 in the assay could trigger such nonspecific lysis. Lysis remained completely specific in the presence of excess rIL-2 (100 U/ml) or after overnight preincubation of target cells with an excess rIFN-y (250 U/ml) (data not shown) .
In Table V , subsequent experiments are shown in which unlabeled (cold) antigen-pulsed targets were mixed with "Cr-labeled (hot) unpulsed targets in order to exclude nonspecific bystander lysis. The three experiments show that CTL strongly lyse hot, peptide-pulsed EBVBLCL. When peptide pulsed targets were added as cold targets to nonpulsed hot targets, the lysis ofthe former did not induce significant lysis of the latter, bystander targets. Three cold targets were tested : EBVBLCL, K562 (a human NK target), and a CTL clone. Other experiments showed that killing was an active, temperature-and contact-dependent process, including Cat+ influx in CTL immediately upon activation by target cells (not shown) . Thus, the effector phase oflysis by CD4+ CTL is entirely specific and does not induce bystander lysis.
Cold Target Competition Experiments. To further confirm the specificity oflysis, cold target competition experiments were carried out. Fig. 2 -425  60  80 53  72  72  21  31  24  3  -0  7  0  6  0  0  0  0  0   NIC8  r65 kD hsp  0  0  0  5  5  0  0  0  0  412-425  27  36  24  32  22  13  21  21  0  -0  2  3  1  0  0  3  0  0   N3A9  r65 kD hsp  0  0  0  0  0  0  0  0  0  412-425  50  35  59  35  42  35  21  32 ample. Lysis of peptide-pulsed EBVBLCL could be competed away in a dosedependent fashion by cold EBVBLCL that had been pulsed with the same peptide ( Fig. 2 A) but not by the nonpulsed cold target (Fig . 2 B) . Peptide-pulsed but not unpulsed EBVBLCL were very efficient in competing away lysis of peptide pulsed CTL targets: (Fig. 2, C and D) . When peptide-pulsed or nonpulsed CTL were used as cold competitors for peptide-pulsed EBVBLCL, a very high spontaneous release was observed because, as expected, these cold CTL efficiently lysed peptide pulsed EBVBLCL (data not shown) . Similar data were obtained for another CTL clone. Thus, although CD4 + CTL efficiently lyse peptide-pulsed CTL targets, they bind more efficiently to EBVBLCL targets. This may also explain the often lower levels of lysis that are observed with CTL as compared with EBVBLCL targets (see Table III , A and B) .
Effect of Target Cell or Efector Cell Prepulsing with Peptide. We next tried to replace the prepulsing oftarget cells with peptide by adding free peptide into the assay. Even very high peptide concentration (up to 100 Ag/ml) gave suboptimal lysis as compared with lysis of targets that had been pulsed overnight (5 Ag/ml) (not shown) . This was unexpected since in other studies, the addition of free (tetanus toxoid) peptide to EBVBLCL led to an almost immediate Ca" influx in an antigen-specific CD4+ T cell clone (27) . Besides considering other explanations (the slow HLApeptide complex formation [28] ; the higher complexity of target cell lysis as compared with merely TCR/CD3 signaling; the induction of peptide-dependent selfmediated CTL killing in the presence of the free peptide), we tested whether the direct binding of free peptide to the TCR possibly interfered with (or led to) target cell killing. Effector cells were preincubated overnight with peptide and then added to peptide pulsed or nonpulsed target cells (Table VI) . The preincubation of CTL did not result in lysis of unpulsed EBVBLCL, suggesting that the formation of a functional TCRpeptide-MHC complex did not take place under these conditions. Lysis of peptide-pulsed target cells was not abrogated, showing that CTL peptide pretreatment did not block TCRmediated recognition ofMHC bound peptide. On the other hand, quantitative differences were observed: at higher E/T ratios, less efficient killing by pretreated CTL was seen, probably as a result of "cold effector" competition with peptide pulsed targets. At lower E/T ratios, killing was enhanced rather than inhibited. This could be accounted for by the preactivation of CTLs by peptide, and based on the above results, is not a consequence of enhanced TCR antigen-MHC complex formation by TCRbound free peptide.
Discussion
Until recently, cell-mediated immunity to intracellular organisms was thought to depend exclusively on CD4+ antigen-specific helper T lymphocytes: upon acti- vation by antigen/MHC class II, these cells would release lymphokines such as IFN-1' and thereby "help" or activate antimicrobial effector functions in the macrophage . This relatively simple scenario has recently been challenged, first by observations in a number of experimental infections in mice, including infections with Mycobacteria sp., where CD4 + and CD8+ CTL could be isolated that were able to lyse macrophages (reviewed in reference 2) . Those studies led us and others to reexamine the type of effector cells that were generated in the human immune response to mycobacteria . In summary, it was found that mycobacteria highly efficiently induced -BLCL  416-439  79  20  22  17  35  69  63  23   EBV-BLCL  -0  4  7  2  9  0  0  6 antigen-specific, HLA-restricted CD4+ and CD8 + CTLs, as well as antigen nonspecific unrestricted killer cells (3) (4) (5) . Each ofthese effector cells lysed macrophages. Recent studies in which rIL-2, rIFN-, y, or purified protein derivative (PPD) was injected into lepromatous leprosy patients' skin (29) (30) (31) , and other studies in which in situ hybridization techniques were used (32) have also indirectly supported an important role for cytotoxic T cells in leprosy. Based on these new findings, the classical concept of cell-mediated immunity needs to be reconsidered, since it has become apparent that not only "macrophage-help" but also "macrophage-lysis" may be an effector mechanism in the cellular immune response to mycobacteria . We therefore wanted to gain further insight into the antigen specificity and function of CTL directed towards mycobacterial pathogens. We have demonstrated earlier that the mycobacterial 65-kD hsp is an important target antigen for CD4+ CTL (3, 5) . These CTL were readily detectable after a single antigen exposure in vitro.
We have now analyzed the CTL response to this immunodominant antigen, using a panel of CTL clones . These CD4+ CD8' CTL recognize M. leprae 65-kD hsp peptides presented by HLA class II molecules and display strong cytotoxic activity towards specific peptide-pulsed EBVBLCL target cells. Further experiments have extended these results to macrophages as target cells (data not shown) . At least four different 65-kD hsp epitopes are able to trigger CTLs . Lysis of target cells was entirely specific and did not result in bystander lysis of EBVBLCL, tumor cells or other CTL clones, although the CD4+ CTL release nonspecific serine esterases upon activation (unpublished observations) . As far as we are aware, this is one of the first examples of peptide-specific CTL in a human infectious disease caused by intracellular parasites. Two other recombinant M. leprae antigens carry epitopes for CD4+ cytotoxic T cell clones, namely the recombinant 18-kD antigen and a newly defined molecule, 13B3 (33) . These findings are in agreement with ours, and show that also non-65-kD antigens can be recognized by CD4' CTL. We are presently also investigating other M. leprae antigens for their ability to serve as CTL target antigens . It will also be important to correlate our findings to the capacity of these CTL to produce lymphokines, since in mice (34) and maybe also in man (36) CD4+ Thl but not Th2 cells possess lytic potential.
An unexpected and novel finding in the present study was that CD4+ CTLs are able to lyse CD4+ or CD8* CTL clones that bear the proper HLA class II/peptide ligand . CTL are thought to be resistant to self-mediated lysis. Although during target cell killing CTL can avoid self-mediated killing by the unidirectional delivery oflytic granule compounds specifically to the target cell (36) , also an active protection of CTL against lytic components has been proposed (e.g., [8] [9] [10] , since CTL are unusually or sometimes even completely resistant to lysis by CTL or CTL products. For instance, cloned CTL are highly resistant to lysis by (other or self) CTL in a lectin-dependent cytotoxicity assay (14) . In another study, a CTL clone efficiently lysed noncytotoxic helper T cells but only marginally lysed CTL targets, although the latter were properly recognized as evident from cold target competition experiments (12) . A good correlation was found between cytotoxic capacity and resistance of CTL clones (13, 18) . In contrast to their target cells, CTL themselves are highly resistant to lysis by purified CTL-derived cytotoxic granules (11, 14, 15) , by highly purified perforin (17, 37) . The same was found for primary, uncloned CTL (11) .
It should be pointed out, however, that these studies were performed with murine CTL that were almost always of the CD8' phenotype. These CTL may well differ from our human CD4' CTL. Our 65-kD hsp-specific CTL only lysed CTL targets that had been pulsed with free peptide but not with native hsp 65, suggesting that T cells do not endocytose and/or process native antigen. An exception may be antigens that specifically bind to recycling T cell membrane molecules. For instance, the gp120 HIV protein binds to CD4, is endocytosed, processed, and then presented to gp120-specific CD4+ CTL that subsequently lyse CD4' class II' target cells (38) . Our CTL do not give bystander lysis. This finding contrasts with the recent suggestion that activated CTL have detectable affinity for self MHC, as determined by bystander lysis of autologous or syngeneic target cells (39) . Differences in target and effector cells may explain these discrepant results. Peptide preincubation ofeffector cells did not lead to lysis of unpulsed targets, showing that if free peptide can bind to the TCR at all, it is unable to induce the formation ofa functional peptide-MHC-TCR complex. Peptide preincubation of effector cells did not also abrogate lysis ofpeptide preincubated target cells, but led to more efficient lysis at lower E/T ratios, probably as a result of CTL preactivation by self presentation .
What is the possible in vivo relevance of CTL-mediated T cell killing? It is conceivable that CTL that lyse M. leprae-infected macrophages, become exposed to the intracellular breakdown products of the target cell, including polypeptides of the highly abundant 65-kD hsp of the infecting organism. These peptides might then bind to class II on the CTL surface and render them targets for CTL-mediated lysis. Mycobacterial granulomas in particular may contain abundant cellular and bacterial debris including such peptides . Cytolytic T-T interactions may be involved in downregulating local T cell responses and represent a novel immunoregulatory pathway that would exclusively be found in man, since murine T cells do not express MHC class II. Human T cell clones can indeed present antigen (our unpublished observations; 40), and cytotoxic T-T cell interactions may contribute to the depletion of CD4+ T cells in HIV infections (38) . Regulatory anticlonotypic cytotoxic T-T cell interactions have also been described in experimental autoimmune encephalomyelitis in mice (41) .
Another immunoregulatory pathway in which mycobacterial antigen-reactive CTL may be involved is the downregulation ofspecific B cell responses (42) . Because antigenspecific B cells express specific Ig receptors, they are much more efficient in the uptake, and hence presentation of processed antigen to T cells when compared with nonspecific B cells. It is conceivable that the CTL-mediated selective killing ofspecific B cells may, at least in part, explain why tuberculoid leprosy patients are good CTL responders to M. leprae and have low specific antibody titers, whereas the opposite is seen in lepromatous patients.
In conclusion, we have shown that mycobacterial peptide-specific HLA class II-restricted CD4' T cell clones display strong specific cytolytic activity towards both APCs, and, unexpectedly, CD4' and CD8' CTL clones, including themselves. Since, in contrast to murine T cells human T cells express class II, CTL-mediated T cell killing may represent a novel immunoregulatory pathway in man.
Summary
Mycobacterial antigens not only stimulate Th cells that produce macrophageactivating factors, but also CD4' and CD8' CTL that lyse human macrophages.
The mycobacterial recombinant 65-kD hsp was previously found to be an important target antigen for polyclonal CD4' CTL. Because of the major role of 65-kD hsp in the immune response to mycobacterial as well as autoantigens, we have studied CTL activity to this protein at the clonal level. HLA-DR or HLA-DQ, restricted, CD4+CD8-T cell clones that recognize different peptides of the M. leprae 65-kD hsp strongly lysed EBV BLCL pulsed with specific but not irrelevant peptide . No bystander lysis of B cells, T cells, or tumor cells was seen. Target cell lysis could not be triggered by PMA + Ca" ionophore alone and depended on active metabolism . Interestingly, these CD4+ CTL also strongly lysed themselves and other HLA-class II compatible CD4+ (TCRa/(3 or -y/b) or CD8 + CTL clones in the presence of peptide, suggesting that CTL are not actively protected from CTLmediated lysis. Cold target competition experiments suggested that EBVBLCL targets were more efficiently recognized than CD4 + CTL targets . These results demonstrate that hsp65 peptide-specific HLA class II-restricted CD4 + T cell clones display strong peptide-dependent cytolytic activity towards both APCs, and, unexpectedly, CD4+ and CD8+ CTL clones, including themselves. Since, in contrast to murine T cells human T cells express class II, CTL-mediated T cell killing may represent a novel immunoregulatory pathway in man.
